EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte StudieLeserbrief

Lessons from a failed randomized controlled trial of speech pathology intervention in vocal cord dysfunction

Joo Koh iD, Debra Phyland iD, Laurence Ruane, Adriana Avram, Elizabeth Leahy, Kenneth K Lau iD, Martin MacDonald iD, Paul Leong, Malcolm Baxter, Philip G Bardin iD

Respirology · 2023

DOI: 10.1111/resp.14477 ↗

At a glance

Randomisierte kontrollierte Studie in Respirology, 2023. Written by Joo Koh and 9 co-authors. Institution: Department of Otolaryngology, Head and Neck Surgery, Monash Health, Melbourne, Victoria, Australia. Major MEDLINE topics: Speech-Language Pathology, Vocal Cord Dysfunction, Asthma, Laryngeal Diseases. Cited 5 times so far (Crossref); 8 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

To the Editor: We write to communicate as a Correspondence our followup experience in the conduct of a randomized controlled trial (RCT) to evaluate speech pathology treatment for vocal cord dysfunction (VCD)/inducible laryngeal obstruction (ILO).Our previously published work in Respirology has highlighted the role of speech pathology treatment in VCD/ILO.1,2 Evidence for speech pathology intervention is largely based on observational data and a RCT was subsequently commenced.This study had to be terminated prematurely due to a number of difficulties that merit reporting here to inform and improve future studies in the field.VCD/ILO due to vocal cord adduction during inspiration causes respiratory symptoms, chiefly breathlessness.3,4 This is particularly debilitating in patients with co-existing airways disease such as asthma, often leading to overtreatment with oral corticosteroids.5 The most prevalent treatment utilizes speech pathology therapy 6 but RCT-based evidence is needed to verify the efficacy of this approach in VCD/ILO.A randomized, single centre, single blind, placebocontrolled trial was designed.Eligible patients with newly diagnosed VCD/ILO 3 were recruited from our VCD Multidisciplinary Team (MDT) clinic. 2 Eligible patients were naïve to treatment and randomized to either speech pathology treatment or placebo.They were informed that they will be assigned randomly to speech pathology treatment (current care but not yet proven to work) or 'placebo' that will entail alternative training exercises not used in speech pathology treatment.Three individual therapy sessions over a period of 6 weeks were done prior to a follow-up assessment at the VCD MDT clinic.Statistical power calculations indicated that 26 patients per group were needed to analyse the co-primary outcomes: health care utilization and changes in the vocal cord dysfunction questionnaire (VCDQ).By February 2020, eight participants were recruited and randomized to active treatment or placebo.However, the COVID -19 pandemic intervened, face-to-face interactions were not possible due to lockdown restrictions and the study was suspended.Speech pathology treatment was then provided via virtual consultation to all recruited participants.In July 2021, with lockdown restrictions easing, the study recruitment was recommenced.Over a three-month period, 10 patients were recruited and randomized.However, several obstacles were encountered (see Table 1) and it became

Subjects

MeSH terms (MEDLINE)

Speech-Language PathologyVocal Cord DysfunctionAsthmaLaryngeal DiseasesHumansVocal CordsDiagnosis, Differential

Author keywords

asthmainducible laryngeal obstructionspeech pathologyvocal cord dysfunction

Authors and institutions

  • Department of Otolaryngology, Head and Neck Surgery, Monash Health, Melbourne, Victoria, Australia.
  • School of Clinical Sciences, Monash Health & University, Melbourne, Victoria, Australia.
  • Australia Monash Lung, Sleep, Allergy and Immunology, Melbourne, Victoria, Australia.
  • Monash Health Diagnostic Imaging, Monash Hospital and University, Melbourne, Victoria, Australia.

ORCID profiles: Joo Koh, Debra Phyland, Kenneth K Lau, Martin MacDonald, Philip G Bardin

Cite

APA

Koh, J., Phyland, D., Ruane, L., Avram, A., Leahy, E., Lau, K. K., MacDonald, M., Leong, P., Baxter, M., & Bardin, P. G. (2023). Lessons from a failed randomized controlled trial of speech pathology intervention in vocal cord dysfunction. Respirology. https://doi.org/10.1111/resp.14477

Vancouver

Koh J, Phyland D, Ruane L, Avram A, Leahy E, Lau KK, et al. Lessons from a failed randomized controlled trial of speech pathology intervention in vocal cord dysfunction. Respirology. 2023. doi:10.1111/resp.14477

BibTeX
@article{Koh2023,
  author = {Koh, Joo and Phyland, Debra and Ruane, Laurence and Avram, Adriana and Leahy, Elizabeth and Lau, Kenneth K and MacDonald, Martin and Leong, Paul and Baxter, Malcolm and Bardin, Philip G},
  title = {Lessons from a failed randomized controlled trial of speech pathology intervention in vocal cord dysfunction},
  journal = {Respirology},
  year = {2023},
  doi = {10.1111/resp.14477}
}
Start for free →